Sharon Manson's 45-year career in oncology nursing includes roles from bedside nurse to assistant vice president of oncology ...

Patients newly diagnosed with multiple myeloma who are transplant ineligible or deferred may benefit from receiving a ...

Jemperli received breakthrough therapy designation by the FDA for locally advanced mismatch repair deficient/microsatellite ...

Braftovi received accelerated approval with Erbitux and mFOLFOX6 for metastatic colorectal cancer with a BRAF V600E mutation.

From a Pro Football Hall of Famer announcing his diagnosis to an R&B star’s latest update, here’s what’s happening in the ...

A combination of Imbruvica and venetoclax showed significantly prolonged progression-free survival in patients with untreated ...

Targeting the estrogen receptor and HER2 pathways improved progression-free survival in patients with HR-positive, ...

The holiday season is here, so here’s a festive poem to remind us that cancer should not control us during this time.

A combination of presurgical Zejula and Jemperli showed promising treatment responses in certain patients with ER-positive, ...

Disorganization, Smith said, is a common theme when it comes to the challenges around coordinating cancer care for a loved ...

A study showed that patients with prostate cancer should consider the long-term side effects of treatments before deciding on ...

The first patient was enrolled in a phase 3 trial for patients with non-metastatic uveal melanoma to either receive Kimmtrak ...